Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11130
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSeeman, Egoen
dc.date.accessioned2015-05-16T00:43:03Z
dc.date.available2015-05-16T00:43:03Z
dc.date.issued2010-12-01en
dc.identifier.citationJournal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research; 25(12): 2553-7en
dc.identifier.govdoc20928873en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/11130en
dc.language.isoenen
dc.subject.otherAlendronate.pharmacology.therapeutic useen
dc.subject.otherBone Density.drug effectsen
dc.subject.otherBone Density Conservation Agents.pharmacology.therapeutic useen
dc.subject.otherBone Resorption.drug therapy.physiopathologyen
dc.subject.otherBone and Bones.drug effects.pathology.physiopathology.radiographyen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherTomography, X-Ray Computeden
dc.titleBone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Bone and Mineral Researchen
dc.identifier.affiliationDepartment of Endocrinology and Medicine, Austin Health, University of Melbourne, Melbourne, Australiaen
dc.identifier.doi10.1002/jbmr.261en
dc.description.pages2553-7en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/20928873en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.